Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2019-01-18 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (67 characters) and contains no substantive content, only placeholders and an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2019-01-18 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges clarifying a media report about the company's business. It references a media article and provides a company statement to correct or clarify information. The document length is only 1203 characters, indicating it is a brief announcement rather than a detailed report. There is no financial data, no mention of annual or quarterly results, no audit information, or management changes. It is a regulatory disclosure under stock exchange listing regulations (LODR Regulations 2015). This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-01-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is an invitation to a conference call to discuss the 3QFY19 results of Indoco Remedies Limited. It includes dial-in numbers, date and time of the call, and contact details for further information. There are no financial statements or detailed financial data included, only an announcement of the event. This matches the characteristics of a Call Transcript (CT) document type, but since it is only an invitation and not the transcript itself, it is not a CT. It is also not an Earnings Release (ER) because it does not contain financial highlights or results, only a notice of the call. Given the content and length (1919 characters), it is an announcement related to a conference call. The best fitting category is Call Transcript (CT) as it is the closest category for conference call related documents, even though this is an invitation rather than a transcript. Confidence is high due to clear mention of conference call details and absence of other report types.
2019-01-15 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is extremely short (377 characters) and appears to be a letter or communication addressed to stock exchanges (BSE Limited and National Stock Exchange of India Limited) with listing department details. There is no substantive financial data, report content, or detailed information. It does not contain any financial statements, management discussion, or regulatory disclosures. Given the brevity and nature, it is likely a Regulatory Filing (RNS) as a general communication or notice to exchanges without specific report content.
2019-01-10 English
Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (366 characters) and consists only of an address or header information related to stock exchanges and listing departments. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed information. Given the lack of content and the nature of the text, it is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other categories.
2019-01-07 English
Updates
Regulatory Filings
2018-11-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.